Emerging concepts in cardiovascular disease risk assessment: where do women fit in?

Area of Science:

• Cardiovascular Medicine
• Women's Health
• Preventive Cardiology

Background:

• Current cardiovascular disease (CVD) risk assessment tools have limitations in accurately evaluating risk in women.
• Traditional risk assessment strategies may not fully capture the nuances of CVD in diverse female populations.
• Evolving understanding of CVD in women necessitates a re-evaluation of existing risk assessment protocols.

Purpose of the Study:

• To identify current limitations in cardiovascular disease (CVD) risk assessment for women.
• To review the existing process for CVD risk assessment in women.
• To explore the role of novel risk factors in improving CVD risk stratification for women.

Main Methods:

• Comprehensive review of existing medical literature focusing on women's cardiovascular health.
• Analysis of the efficacy and limitations of current CVD risk assessment tools.
• Exploration of emerging risk factors and their potential integration into risk models.

Main Results:

• The Framingham Risk Score demonstrates limitations in accurately assessing CVD risk across diverse female populations.
• Discrepancies in treatment goals for similar risk factor levels between genders highlight the need for gender-specific approaches.
• Current preventive guidelines for women emphasize a lifetime perspective on CVD risk.

Conclusions:

• CVD risk assessment in women is an evolving field requiring advanced tools.
• Novel markers like high-sensitivity C-reactive protein, family history, and functional capacity can enhance risk stratification in women.
• Nurse practitioners play a vital role in assessing, educating, and treating women at risk for CVD.